Advertisement

Breast Cancer Disparities

How Can We Leverage Genomics to Improve Outcomes?

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Newman L.A.
        • Kaljee L.M.
        Health disparities and triple-negative breast cancer in African American women: a review.
        JAMA Surg. 2017; 152: 485-493
        • Chlebowski R.T.
        • Hendrix S.L.
        • Langer R.D.
        • et al.
        Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
        JAMA. 2003; 289: 3243-3253
        • DeSantis C.E.
        • Fedewa S.A.
        • Goding Sauer A.
        • et al.
        Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
        CA Cancer J Clin. 2016; 66: 31-42
        • U.S. Cancer Statistics Working Group
        United States cancer statistics: 1999–2013 incidence and mortality web-based report.
        U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta (GA)2016 (Available at:) (Accessed September 6, 2016)
        • Kohler B.A.
        • Sherman R.L.
        • Howlader N.
        • et al.
        Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state.
        J Natl Cancer Inst. 2015; 107: djv048
        • Bowen R.L.
        • Duffy S.W.
        • Ryan D.A.
        • et al.
        Early onset of breast cancer in a group of British black women.
        Br J Cancer. 2008; 98: 277-281
        • Copson E.
        • Maishman T.
        • Gerty S.
        • et al.
        Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.
        Br J Cancer. 2014; 110: 230-241
        • Rapiti E.
        • Pinaud K.
        • Chappuis P.O.
        • et al.
        Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
        Cancer Med. 2017; 6: 526-536
        • Der E.M.
        • Gyasi R.K.
        • Tettey Y.
        • et al.
        Triple-negative breast cancer in Ghanaian women: the Korle Bu Teaching Hospital experience.
        Breast J. 2015; 21: 627-633
        • Ohene-Yeboah M.
        • Adjei E.
        Breast cancer in Kumasi, Ghana.
        Ghana Med J. 2012; 46: 8-13
        • Jiagge E.
        • Jibril A.S.
        • Chitale D.
        • et al.
        Comparative analysis of breast cancer phenotypes in African American, White American, and West Versus East African patients: correlation between African ancestry and triple-negative breast cancer.
        Ann Surg Oncol. 2016; 23: 3843-3849
        • Agboola A.J.
        • Musa A.A.
        • Wanangwa N.
        • et al.
        Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
        Breast Cancer Res Treat. 2012; 135: 555-569
        • Nwafor C.C.
        • Keshinro S.O.
        Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience.
        Niger J Clin Pract. 2015; 18: 553-558
        • Ly M.
        • Antoine M.
        • Dembele A.K.
        • et al.
        High incidence of triple-negative tumors in sub-Saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital.
        Oncology. 2012; 83: 257-263
        • Aiad H.A.
        • Wahed M.M.
        • Asaad N.Y.
        • et al.
        Immunohistochemical expression of GPR30 in breast carcinoma of Egyptian patients: an association with immunohistochemical subtypes.
        APMIS. 2014; 122: 976-984
        • Salhia B.
        • Tapia C.
        • Ishak E.A.
        • et al.
        Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology.
        BMC Womens Health. 2011; 11: 44
        • Rais G.
        • Raissouni S.
        • Aitelhaj M.
        • et al.
        Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.
        BMC Womens Health. 2012; 12: 35
        • Bennis S.
        • Abbass F.
        • Akasbi Y.
        • et al.
        Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.
        BMC Res Notes. 2012; 5: 436
        • Cherbal F.
        • Gaceb H.
        • Mehemmai C.
        • et al.
        Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
        Breast Dis. 2015; 35: 95-102
        • Jemal A.
        • Fedewa S.A.
        Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women?.
        Breast Cancer Res Treat. 2012; 135: 867-873
        • Newman L.A.
        • Griffith K.A.
        • Jatoi I.
        • et al.
        Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.
        J Clin Oncol. 2006; 24: 1342-1349
        • Albain K.S.
        • Unger J.M.
        • Crowley J.J.
        • et al.
        Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
        J Natl Cancer Inst. 2009; 101: 984-992
        • Hershman D.L.
        • Unger J.M.
        • Barlow W.E.
        • et al.
        Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
        J Clin Oncol. 2009; 27: 2157-2162
        • Sparano J.A.
        • Wang M.
        • Zhao F.
        • et al.
        Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
        J Natl Cancer Inst. 2012; 104: 406-414
        • Chlebowski R.T.
        • Chen Z.
        • Anderson G.L.
        • et al.
        Ethnicity and breast cancer: factors influencing differences in incidence and outcome.
        J Natl Cancer Inst. 2005; 97: 439-448
        • Akbari M.R.
        • Donenberg T.
        • Lunn J.
        • et al.
        The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
        Clin Genet. 2014; 85: 64-67
        • Trottier M.
        • Lunn J.
        • Butler R.
        • et al.
        Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas.
        Clin Genet. 2016; 89: 328-331
        • van der Merwe N.C.
        • Hamel N.
        • Schneider S.R.
        • et al.
        A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.
        Clin Genet. 2012; 81: 179-184
        • Zhang B.
        • Fackenthal J.D.
        • Niu Q.
        • et al.
        Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.
        Fam Cancer. 2009; 8: 15-22
        • Mefford H.C.
        • Baumbach L.
        • Panguluri R.C.
        • et al.
        Evidence for a BRCA1 founder mutation in families of West African ancestry.
        Am J Hum Genet. 1999; 65: 575-578
        • Oluwagbemiga L.A.
        • Oluwole A.
        • Kayode A.A.
        Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.
        Springerplus. 2012; 1: 83
        • Karami F.
        • Mehdipour P.
        A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
        Biomed Res Int. 2013; 2013: 928562
        • Zhang J.
        • Fackenthal J.D.
        • Zheng Y.
        • et al.
        Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.
        Breast Cancer Res Treat. 2012; 134: 889-894
        • Mersha T.B.
        • Abebe T.
        Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities.
        Hum Genom. 2015; 9: 1
        • Zeng X.
        • Chakraborty R.
        • King J.L.
        • et al.
        Selection of highly informative SNP markers for population affiliation of major US populations.
        Int J Legal Med. 2016; 130: 341-352
        • Shriver M.D.
        • Parra E.J.
        • Dios S.
        • et al.
        Skin pigmentation, biogeographical ancestry and admixture mapping.
        Hum Genet. 2003; 112: 387-399
        • Tian C.
        • Hinds D.A.
        • Shigeta R.
        • et al.
        A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping.
        Am J Hum Genet. 2006; 79: 640-649
        • Stefflova K.
        • Dulik M.C.
        • Barnholtz-Sloan J.S.
        • et al.
        Dissecting the within-Africa ancestry of populations of African descent in the Americas.
        PLoS One. 2011; 6: e14495
        • Rao R.
        • Rivers A.
        • Rahimi A.
        • et al.
        Genetic Ancestry using Mitochondrial DNA in patients with Triple-negative breast cancer (GAMiT study).
        Cancer. 2017; 123: 107-113
        • Davis M.B.
        • Walens A.
        • Hire R.
        • et al.
        Distinct Transcript Isoforms of the Atypical Chemokine Receptor 1 (ACKR1)/Duffy Antigen Receptor for Chemokines (DARC) Gene Are Expressed in Lymphoblasts and Altered Isoform Levels Are Associated with Genetic Ancestry and the Duffy-Null Allele.
        PLoS One. 2015; 10: e0140098
        • Palmer J.R.
        • Ruiz-Narvaez E.A.
        • Rotimi C.N.
        • et al.
        Genetic susceptibility loci for subtypes of breast cancer in an African American population.
        Cancer Epidemiol Biomarkers Prev. 2013; 22: 127-134
        • Ruiz-Narvaez E.A.
        • Sucheston-Campbell L.
        • Bensen J.T.
        • et al.
        Admixture mapping of African-American Women in the AMBER consortium identifies new loci for breast cancer and estrogen-receptor subtypes.
        Front Genet. 2016; 7: 170
        • Haddad S.A.
        • Ruiz-Narvaez E.A.
        • Haiman C.A.
        • et al.
        An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium.
        Carcinogenesis. 2016; 37: 870-877
        • Huo D.
        • Feng Y.
        • Haddad S.
        • et al.
        Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
        Hum Mol Genet. 2016; 112: 387-399
        • Wu Y.
        • Sarkissyan M.
        • Vadgama J.V.
        Epigenetics in breast and prostate cancer.
        Methods Mol Biol. 2015; 1238: 425-466
        • Ambrosone C.B.
        • Young A.C.
        • Sucheston L.E.
        • et al.
        Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.
        Oncotarget. 2014; 5: 237-248
        • Song M.A.
        • Brasky T.M.
        • Marian C.
        • et al.
        Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
        Epigenetics. 2015; 10: 1177-1187
        • Cappetta M.
        • Berdasco M.
        • Hochmann J.
        • et al.
        Effect of genetic ancestry on leukocyte global DNA methylation in cancer patients.
        BMC Cancer. 2015; 15: 434
        • Williams D.R.
        • Mohammed S.A.
        • Shields A.E.
        Understanding and effectively addressing breast cancer in African American women: unpacking the social context.
        Cancer. 2016; 122: 2138-2149
        • Gruenewald T.L.
        • Seeman T.E.
        • Karlamangla A.S.
        • et al.
        Allostatic load and frailty in older adults.
        J Am Geriatr Soc. 2009; 57: 1525-1531
        • Seeman T.
        • Epel E.
        • Gruenewald T.
        • et al.
        Socio-economic differentials in peripheral biology: cumulative allostatic load.
        Ann N Y Acad Sci. 2010; 1186: 223-239
        • Geronimus A.T.
        • Hicken M.
        • Keene D.
        • et al.
        “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States.
        Am J Public Health. 2006; 96: 826-833
        • Beckie T.M.
        A systematic review of allostatic load, health, and health disparities.
        Biol Res Nurs. 2012; 14: 311-346
        • Parente V.
        • Hale L.
        • Palermo T.
        Association between breast cancer and allostatic load by race: National Health and Nutrition Examination Survey 1999-2008.
        Psychooncology. 2013; 22: 621-628
        • Romens S.E.
        • McDonald J.
        • Svaren J.
        • et al.
        Associations between early life stress and gene methylation in children.
        Child Dev. 2015; 86: 303-309
        • Juster R.P.
        • Russell J.J.
        • Almeida D.
        • et al.
        Allostatic load and comorbidities: A mitochondrial, epigenetic, and evolutionary perspective.
        Dev Psychopathol. 2016; 28: 1117-1146
        • Stewart P.A.
        • Luks J.
        • Roycik M.D.
        • et al.
        Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer.
        PLoS One. 2013; 8: e82460
        • Keenan T.
        • Moy B.
        • Mroz E.A.
        • et al.
        Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence.
        J Clin Oncol. 2015; 33: 3621-3627
        • Ademuyiwa F.O.
        • Tao Y.
        • Luo J.
        • et al.
        Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
        Breast Cancer Res Treat. 2017; 161: 491-499
        • Kroenke C.H.
        • Sweeney C.
        • Kwan M.L.
        • et al.
        Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.
        Breast Cancer Res Treat. 2014; 144: 689-699
        • Sweeney C.
        • Bernard P.S.
        • Factor R.E.
        • et al.
        Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.
        Cancer Epidemiol Biomarkers Prev. 2014; 23: 714-724
        • Newman L.A.
        • Reis-Filho J.S.
        • Morrow M.
        • et al.
        The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.
        Ann Surg Oncol. 2015; 22: 874-882
        • Lehmann B.D.
        • Bauer J.A.
        • Chen X.
        • et al.
        Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
        J Clin Invest. 2011; 121: 2750-2767
        • Burstein M.D.
        • Tsimelzon A.
        • Poage G.M.
        • et al.
        Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.
        Clin Cancer Res. 2015; 21: 1688-1698
        • Masuda H.
        • Baggerly K.A.
        • Wang Y.
        • et al.
        Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.
        Clin Cancer Res. 2013; 19: 5533-5540
        • Lehmann B.D.
        • Jovanovic B.
        • Chen X.
        • et al.
        Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection.
        PLoS One. 2016; 11: e0157368
        • Lindner R.
        • Sullivan C.
        • Offor O.
        • et al.
        Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
        PLoS One. 2013; 8: e71915
        • Giuliano A.E.
        • Connolly J.L.
        • Edge S.B.
        • et al.
        Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
        CA Cancer J Clin. 2017; 67: 290-303
        • Roberts M.C.
        • Weinberger M.
        • Dusetzina S.B.
        • et al.
        Racial variation in the uptake of oncotype DX testing for early-stage breast cancer.
        J Clin Oncol. 2016; 34: 130-138
        • Cress R.D.
        • Chen Y.S.
        • Morris C.R.
        • et al.
        Underutilization of gene expression profiling for early-stage breast cancer in California.
        Cancer Causes Control. 2016; 27: 721-727
        • Ricks-Santi L.J.
        • McDonald J.T.
        Low utility of Oncotype DX in the clinic.
        Cancer Med. 2017; 6: 501-507
      1. Surveillance Research Program, Available at: https://seer.cancer.gov/faststats/selections. Accessed April 2, 2017.

        • Francies F.Z.
        • Wainstein T.
        • De Leeneer K.
        • et al.
        BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.
        BMC Cancer. 2015; 15: 912
        • Pal T.
        • Bonner D.
        • Cragun D.
        • et al.
        A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
        Cancer. 2015; 121: 4173-4180
        • Sharma P.
        • Klemp J.R.
        • Kimler B.F.
        • et al.
        Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.
        Breast Cancer Res Treat. 2014; 145: 707-714
        • Biunno I.
        • Aceto G.
        • Awadelkarim K.D.
        • et al.
        BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan.
        Fam Cancer. 2014; 13: 437-444
        • Greenup R.
        • Buchanan A.
        • Lorizio W.
        • et al.
        Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
        Ann Surg Oncol. 2013; 20: 3254-3258
        • Pal T.
        • Bonner D.
        • Kim J.
        • et al.
        Early onset breast cancer in a registry-based sample of African-American women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
        Breast J. 2013; 19: 189-192
        • Judkins T.
        • Rosenthal E.
        • Arnell C.
        • et al.
        Clinical significance of large rearrangements in BRCA1 and BRCA2.
        Cancer. 2012; 118: 5210-5216
        • Fackenthal J.D.
        • Zhang J.
        • Zhang B.
        • et al.
        High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.
        Int J Cancer. 2012; 131: 1114-1123
        • Donenberg T.
        • Lunn J.
        • Curling D.
        • et al.
        A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
        Breast Cancer Res Treat. 2011; 125: 591-596
        • Zhang J.
        • Fackenthal J.D.
        • Huo D.
        • et al.
        Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population.
        Breast Cancer Res Treat. 2010; 124: 573-577
        • John E.M.
        • Miron A.
        • Gong G.
        • et al.
        Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
        JAMA. 2007; 298: 2869-2876
        • Awadelkarim K.D.
        • Aceto G.
        • Veschi S.
        • et al.
        BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors.
        Breast Cancer Res Treat. 2007; 102: 189-199
        • Malone K.E.
        • Daling J.R.
        • Doody D.R.
        • et al.
        Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
        Cancer Res. 2006; 66: 8297-8308
        • Fackenthal J.D.
        • Sveen L.
        • Gao Q.
        • et al.
        Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients.
        J Med Genet. 2005; 42: 276-281
        • Nanda R.
        • Schumm L.P.
        • Cummings S.
        • et al.
        Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
        JAMA. 2005; 294: 1925-1933
        • Gao Q.
        • Adebamowo C.A.
        • Fackenthal J.
        • et al.
        Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer.
        Hum Genet. 2000; 107: 192-194
        • Yawitch T.M.
        • van Rensburg E.J.
        • Mertz M.
        • et al.
        Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer.
        S Afr Med J. 2000; 90: 788
        • Gao Q.
        • Tomlinson G.
        • Das S.
        • et al.
        Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
        Hum Genet. 2000; 107: 186-191
        • Panguluri R.C.
        • Brody L.C.
        • Modali R.
        • et al.
        BRCA1 mutations in African Americans.
        Hum Genet. 1999; 105: 28-31
        • Gao Q.
        • Neuhausen S.
        • Cummings S.
        • et al.
        Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.
        Am J Hum Genet. 1997; 60: 1233-1236
        • Martin D.N.
        • Boersma B.J.
        • Yi M.
        • et al.
        Differences in the tumor microenvironment between African-American and European-American breast cancer patients.
        PLoS One. 2009; 4: e4531
        • Field L.A.
        • Love B.
        • Deyarmin B.
        • et al.
        Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women.
        Cancer. 2012; 118: 1334-1344
        • Grunda J.M.
        • Steg A.D.
        • He Q.
        • et al.
        Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer.
        BMC Res Notes. 2012; 5: 248
        • Tao L.
        • Gomez S.L.
        • Keegan T.H.
        • et al.
        Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study.
        Cancer Epidemiol Biomarkers Prev. 2015; 24: 1039-1045
        • D'Arcy M.
        • Fleming J.
        • Robinson W.R.
        • et al.
        Race-associated biological differences among Luminal A breast tumors.
        Breast Cancer Res Treat. 2015; 152: 437-448
        • Churpek J.E.
        • Walsh T.
        • Zheng Y.
        • et al.
        Inherited predisposition to breast cancer among African American women.
        Breast Cancer Res Treat. 2015; 149: 31-39
        • Newman B.
        • Mu H.
        • Butler L.M.
        • et al.
        Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
        JAMA. 1998; 279: 915-921
        • Huo D.
        • Hu H.
        • Rhie S.K.
        • et al.
        Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
        JAMA Oncology. 2017;